Exenatide + Insulin
Phase 2/3Completed 0 views this week 0 watching💤 Quiet
Interest: 38/100
38
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Stress Hyperglycemia
Conditions
Stress Hyperglycemia
Trial Timeline
Jan 1, 2015 → Dec 1, 2016
NCT ID
NCT01969149About Exenatide + Insulin
Exenatide + Insulin is a phase 2/3 stage product being developed by Eli Lilly for Stress Hyperglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01969149. Target conditions include Stress Hyperglycemia.
What happened to similar drugs?
8 of 20 similar drugs in Stress Hyperglycemia were approved
Approved (8) Terminated (1) Active (12)
Hype Score Breakdown
Clinical
15
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02432976 | Phase 2/3 | Completed |
| NCT01969149 | Phase 2/3 | Completed |
| NCT00099333 | Phase 2 | Completed |
Competing Products
20 competing products in Stress Hyperglycemia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Duloxetine + placebo | Eli Lilly | Phase 2 | 35 |
| agenT-797 | MiNK Therapeutics | Phase 1 | 19 |
| Thermal stress and performance without a pre-cooling protocol | Petros Pharmaceuticals | Pre-clinical | 16 |
| solifenacin | Astellas Pharma | Approved | 43 |
| Sivelestat | Eli Lilly | Phase 1/2 | 32 |
| Duloxetine + Placebo | Eli Lilly | Phase 3 | 40 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| Duloxetine + Placebo | Eli Lilly | Phase 3 | 40 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| Duloxetine hydrochloride | Eli Lilly | Phase 3 | 36 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| duloxetine + Placebo | Eli Lilly | Phase 2 | 35 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| duloxetine HCl | Eli Lilly | Approved | 43 |
| Orforglipron + Placebo | Eli Lilly | Phase 3 | 47 |
| Duloxetine hydrochloride + placebo | Eli Lilly | Approved | 43 |
| Duloxetine + Placebo | Eli Lilly | Phase 3 | 40 |
| duloxetine + placebo | Eli Lilly | Phase 3 | 40 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| Duloxetine Hydrochloride + placebo | Eli Lilly | Phase 3 | 40 |